5 Developments With Cancer Immunotherapy – AJMC.com Managed Markets Network
|
5 Developments With Cancer Immunotherapy
AJMC.com Managed Markets Network With clinical trials evaluating several different combinations of immunotherapy agents, can we use predictive biomarkers as an early sign of patient response? A study recently published in the Journal of Clinical Investigation Insight attempted just that. |
